| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| KALA BIO, Inc. | Director | Common Stock | 10,242 | $35,642 | $3.48 | 15 Jun 2025 | Direct |
| KALA BIO, Inc. | Director | Stock Option (right to buy) | 5,450 | 15 Jun 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| KALA | KALA BIO, Inc. | 15 Jun 2025 | 2 | $0 | 4 | Director | 17 Jun 2025, 20:00 |
| KALA | KALA BIO, Inc. | 11 Jun 2024 | 2 | $0 | 4 | Director | 12 Jun 2024, 20:00 |
| KALA | Kala Pharmaceuticals, Inc. | 22 Jun 2023 | 4 | $0 | 4 | Director | 23 Jun 2023, 20:00 |
| KALA | Kala Pharmaceuticals, Inc. | 31 May 2023 | 2 | $0 | 4 | Director | 02 Jun 2023, 20:00 |
| KALA | Kala Pharmaceuticals, Inc. | 31 Oct 2022 | 1 | $0 | 4 | Director | 01 Nov 2022, 16:12 |
| KALA | Kala Pharmaceuticals, Inc. | 31 Oct 2022 | 0 | $0 | 3 | Director | 01 Nov 2022, 16:11 |